PAEME pharma SRL
PAEME pharma reported total assets of 607,089 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jul 2026).
The score of PAEME pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +15 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PAEME pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 9,150 € | ||||
| Equity | 537,623 € | ||||
| Cash | 47,330 € | ||||
| EBITDA | 16,713 € | ||||
| Total assets | 607,089 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jul 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 23 Jun 2022
PAEME pharma's financial analysis
- Solvency88.6%sector median: 50.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PAEME pharma
PAEME pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0812.307.989
- VAT number
- BE0812307989
- Peppol
- Registered · 0208:0812307989 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jun 2009
- Registered office
- 1020 Brussels
- Latest accounts
- 2025 · filed on 04 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
PAEME pharma (SRL) has been based in Brussels since 2009, active in: business and other management consultancy activities. For 2025, it reports a net profit of 9,150 € and equity of 537,623 €; its revenue is not published. Its solvency stands at 88.6%, above the median of its sector (50.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to PAEME pharma
Companies in the same business, of comparable size and area, outside its group.
- B-werkt Business and other management consultancy activities Antwerp · balance sheet 607,814 €
- Harvest & Hold Business and other management consultancy activities Affligem · balance sheet 607,884 €
- Bovino Business and other management consultancy activities Hotton · balance sheet 607,920 €
- Taste Energy Business and other management consultancy activities Antwerp · balance sheet 606,208 €
- Epona Belgium Business and other management consultancy activities Merchtem · balance sheet 606,201 €
- Point Blank Business and other management consultancy activities Antwerp · balance sheet 606,145 €
- XLP Consult Business and other management consultancy activities Beauvechain · balance sheet 608,045 €
- Publiwest Business and other management consultancy activities Nieuwpoort · balance sheet 605,977 €
Frequently asked questions about PAEME pharma
What is the revenue of PAEME pharma?
PAEME pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of PAEME pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0812307989 for PAEME pharma, if the company is VAT-registered. Its company number (CBE) is 0812.307.989.
Where is the registered office of PAEME pharma?
According to the CBE register, the registered office of PAEME pharma is in 1020 Brussels.
What is the equity of PAEME pharma?
At the close of the 2025 financial year, the equity of PAEME pharma amounts to 537,623 €, a solvency of 88.6% of total assets.
Who manages PAEME pharma?
The register lists 1 active mandates at PAEME pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PAEME pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →